Tag

HemoPalm

Browsing

Canadian Medical Technology Startup ChroMedX Is At A Breakthrough Point With Its Revolutionary HemoPalm Handheld Blood Analyzer

Truly transformational changes are quite uncommon in medicine (such as the mass introduction of anesthesia, antibiotics or X-ray machines, to name a few). They happen once every ten years or so, at best. Most of the changes in this industry are evolutionary improvements. However, Toronto-based ChroMedX Corp (CSE:CHX) (OTC: MNLIF) (FSE:EIY2) is now poised on the verge of a real medical technology breakthrough. The main product of this company is the HemoPalm handheld blood analyzer. This device is much more than just a tightly packed set of precise sensors. it’s a real technological gem, actually. The Canadian startup was founded in 2013 and went public a year later. Now ChroMedX is in final preparations for the HemoPalm launch to the market. If everything goes well (and this reporter doesn’t see a single reason, why wouldn’t it), ChroMedX will manage to seize a major niche in med tech, essentially cornering the market…

5 Reasons Why The Future Of Medical Testing Is Looking Mighty Bright

Over the past two decades, we’ve done much to improve the effectiveness of medical tests but the latest trends are moving in a slightly different direction than they were before. In the not-so-old old days, after a rigorous testing, much of a doctor’s expertise on the patient’s overall condition and the following diagnosis was still more or less “hunch-based”. Today “practicing medicine” first of all means fully relying on the testing process (for liability reasons, in no small terms). Thus, the future of medical testing is closely linked to the ubiquity and accessibility of technologies, which will allow for the most thorough testing and analyses followed by the most exact diagnosis possible. If we’re able to do that, such an approach may change the entire health care model. This transformation may need interim solutions that would have to be tightly integrated with the future early diagnostics methodologies and the workflow…

HemoPalm Blood Analyzer 2.0: Design, Specs, Features and More

ChroMedX Corp., developer of the HemoPalm Handheld Blood Analyzer System, is pleased to announce the finalization of the new HemoPalm 2.0 design.  The new design reflects the evolution of diagnostics moving from laboratory based analysis to point-of-care testing (POCT). The design includes a number of new and updated features for improving diagnostic time and treatment for patients in the hospital, particularly in the ED and ICU and in the field for use by, for example first responders. @heartbeat_trust 5 Modern Devices Needed to Save Lives in Today’s World: The Perfect Kit for a First Responder Team https://t.co/LUM8t9jZdU — Tech Officials (@tech_officials) April 10, 2017 HemoPalm 2.0 Design Features 5” resistive touch screen LCD display for easy navigation and sanitization Micro spectrometer and biosensor analyzer Wifi and Bluetooth capability enables transmittal of patient data to central hub 64-bit quad core CPU USB port for manual data transfer Memory for storing patient…

New Blood Analyzer On The Bloc: HemoPalm Prototype Is Nearing Completion

Well, it’s one of those things: while statisticians claim that violent crime is going down, the police and the newscasters don’t waste another moment telling us that the world’s becoming more dangerous by the minute. And what do the little old us have to rely on nowadays to stay healthy and on top of things? The healthcare system? Yeah, if you’re lucky, don’t have a lot of preexisting conditions, relatively young and gainfully employed. The insurance companies? They have been letting us down lately at an alarming rate and something tells us they’re not nearly done. The helping hand of a friend? They’re all busy checking Twitter and updating their Facebook profiles. So, what else is there? Technology. It sure as hell won’t save the world (and movies like ‘Elysium’ are a great illustration why not) but it might come in into your life at just the right moment, so…